Loading...
XNAS
UTMD
Market cap216mUSD
Jul 10, Last price  
67.96USD
1D
-0.61%
1Q
3.13%
Jan 2017
-6.58%
Name

Utah Medical Products Inc

Chart & Performance

D1W1MN
XNAS:UTMD chart
P/E
19.17
P/S
5.62
EPS
3.54
Div Yield, %
1.80%
Shrs. gr., 5y
-2.47%
Rev. gr., 5y
-1.80%
Revenues
39m
-5.83%
28,753,00028,502,00027,782,00025,916,00025,121,00037,860,00041,552,00040,493,00041,278,00040,157,00039,298,00041,414,00041,998,00046,904,00042,178,00049,054,00052,281,00050,224,00040,903,00038,520,000
Net income
11m
-18.65%
8,168,0007,905,0007,205,0006,258,0006,014,0007,414,00010,169,00011,406,00011,378,00011,843,00012,128,0008,505,00018,554,00014,727,00010,798,00014,788,00016,473,00016,635,00013,874,00011,286,000
CFO
15m
-0.94%
10,853,0007,474,0007,762,0007,226,0007,157,00011,365,00013,563,00012,309,00015,387,00013,801,00014,528,00016,908,00016,834,00017,056,00020,137,00021,203,00021,147,00022,281,00014,831,00014,692,000
Dividend
Dec 16, 20250.31 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
IPO date
Dec 01, 1982
Employees
186
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT